Olon Completes Major Concord Facility Expansion

Editor’s Take: This project reflects Olon’s broader strategy to enhance its technological expertise and create a more integrated global operating model. Learn more about the biopharma industry’s shift toward integrated support.

Olon has completed a major expansion at its Concord, Ohio facility, which has historically focused on chemical synthesis, process development, and early-stage manufacturing. The expansion doubles the facility’s overall production capacity, significantly enhancing its commercial manufacturing capabilities while preserving its established strengths in development and scale-up.

With its expanded infrastructure and technical expertise, Concord is positioned as a strategic U.S. manufacturing hub, enabling it to provide development and production solutions for companies looking to establish or scale manufacturing in the United States.

The expanded site also strengthens Concord’s R&D capabilities in early-stage process development and scale-up, supporting a “right first time” approach that accelerates timelines and reduces variability as projects move from lab to commercial scale. Combined with the new production assets, the site now offers an even stronger end-to-end solution, from process development through commercial supply, providing customers with a reliable U.S. manufacturing partner backed by Olon’s global network.

Paolo Tubertini, CEO of Olon Group, said, “Concord represents an important milestone in our long-term growth strategy. By strengthening the integration of our operations across regions, we are building a more agile and connected organization, enabling us to support increasingly complex projects while providing greater flexibility and reliability to our clients worldwide.”